Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)

Clinical trial NCT04745403 · RECRUITING

Trial details

NCT number: NCT04745403
Sponsor: Lion TCR Pte. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-05-20
Primary completion: 2026-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.